Given their recent hiccups and shortfalls in other trials, I'm sure this extra money will be a great benefit to the company and to investors/shareholders, alleviating the need for any capital raises in short term future.
Ann: Mesoblast Update on Chronic Low Back Pain Program, page-9
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
-0.050(4.67%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.05 | $1.02 | $2.054M | 1.988M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 131630 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 27203 | 6 |
View Market Depth
| Last trade - 10.32am 30/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |